COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,235 Articles (22,733 medRxiv, 8,502 bioRxiv)

Most recent first Previous |  Page 2736: Articles 27351-27360  | Next

Doxycycline and Hydroxychloroquine as Treatment for High-Risk COVID-19 Patients: Experience from Case Series of 54 Patients in Long-Term Care Facilities
Ahmad, I., Alam, M., Saadi, R., Mahmud, S., Saadi, E.
10.1101/2020.05.18.20066902 — Posted: 2020-05-22 Discussion: Onsite
The "Double Eights Mask Brace" Improves the Fit and Protection and Protection of a Basic Surgical Mask Amidst Covid-19 Pandemic
Runde, D. P., Harland, K., Van Heukelom, P., Faine, B., OShaughnessy, P., Mohr, N.
10.1101/2020.05.18.20099325 — Posted: 2020-05-22
Risk stratification of hospitalized COVID-19 patients through comparative studies of laboratory results with influenza
Mei, Y., Weinberg, S. E., Zhao, L., Qi, C., Frink, A., Behdad, A., Ji, P.
10.1101/2020.05.18.20101709 — Posted: 2020-05-22
Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France
Fafi-Kremer, S., Bruel, T., Madec, Y., Grant, R., Tondeur, L., Grzelak, L., Staropoli, I., Anna, F., Souque, P., Mutter, C., Collongues, N., Bolle, A., Velay, A., Lefebvre, N., Mielcarek, M., Meyer, N., Rey, D., Charneau, P., Hoen, B., De Seze, J., Schwartz, O., Fontanet, A.
10.1101/2020.05.19.20101832 — Posted: 2020-05-22 Discussion: Onsite
Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation
Jääskeläinen, A. J., Kuivanen, S., Kekäläinen, E., Ahava, M. J., Loginov, R., Kallio-Kokko, H., Vapalahti, O., Jarva, H., Kurkela, S., Lappalainen, M.
10.1101/2020.05.18.20101618 — Posted: 2020-05-22
Dramatic reduction of psychiatric emergency consultations during lockdown linked to COVID-19 in Paris and suburbs
Pignon, B., Gourevitch, R., Tebeka, S., Dubertret, C., Cardot, H., Dauriac-Le Masson, V., Trebalag, A.-K., Barruel, D., Yon, L., Hemery, F., Loric, M., Rabu, C., Pelissolo, A., Leboyer, M., Schurhoff, F., Pham-Scottez, A.
10.1101/2020.05.19.20095901 — Posted: 2020-05-22
ICU Bed Availability Monitoring and analysis in the Grand Est region of France during the COVID-19 epidemic
ICUBAM Consortium, , josse, j.
10.1101/2020.05.18.20091264 — Posted: 2020-05-21
No evidence for increased transmissibility from recurrent mutations in SARS-CoV-2
van Dorp, L., Richard, D., Tan, C. C., Shaw, L. P., Acman, M., Balloux, F.
10.1101/2020.05.21.108506 — Posted: 2020-05-21 Discussion: Onsite
Trimeric SARS-CoV-2 Spike interacts with dimeric ACE2 with limited intra-Spike avidity
Lui, I., Zhou, X. X., Lim, S. A., Elledge, S., Solomon, P., Rettko, N. J., Zha, B. S., Kirkemo, L. L., Gramespacher, J. A., Liu, J., Muecksch, F., Lorenzi, J. C. C., Schmidt, F., Weisblum, Y., Robbiani, D. F., Nussenzweig, M. C., Hatziioannou, T., Bieniasz, P. D., Rosenberg, O., Leung, K. K., Wells, J. A.
10.1101/2020.05.21.109157 — Posted: 2020-05-21 Discussion: Onsite
An insertion unique to SARS-CoV-2 exhibits superantigenic character strengthened by recent mutations
Cheng, M. H., Zhang, S., Porritt, R. A., Arditi, M., Bahar, I.
10.1101/2020.05.21.109272 — Posted: 2020-05-21 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).